Journal rankings · indicator year 2024
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2024
Immunology journal rankings 2024
88 ranked journals · Subfield in Immunology and Microbiology
Immunology has 88 ranked journals in 2024. The median journal has an OJR of 0.92, below the world average of 1.00, down 0.03 on 2023; Q1 starts at OJR 1.40. The top three are Immunity, Nature reviews. Immunology, and Nature Immunology.
Ranks and citation indicators: 2024. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2021–2023, the window the 2024 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Immunology and Microbiology (5)
88 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2023. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2021–2023, the window the 2024 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2021–2023 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2015 to 2024. | Compare |
|---|---|---|---|---|---|---|---|
1ImmunityCell Press · United States | 5.31Q1 | 19.28 0.59 up from 2023 | 702 | 98% | $10,400 | ||
2Nature reviews. ImmunologyNature Portfolio · United Kingdom | 4.64Q1 | 22.44 4.37 down from 2023 | 476 | 22% | — | ||
3Nature ImmunologyNature Portfolio · United States | 4.27Q1 | 16.14 0.74 down from 2023 | 741 | 44% | $12,690 | ||
4Clinical Reviews in Allergy & ImmunologySpringer Nature · United States | 3.94Q1 | 10.39 0.04 up from 2023 | 143 | 32% | $5,490 | ||
5Cellular and Molecular ImmunologySpringer Nature · China | 3.89Q1 | 12.85 0.23 up from 2023 | 493 | 100% | $5,190 | ||
6Science ImmunologyAmerican Association for the Advancement of Science · United States | 3.84Q1 | 14.56 1.47 down from 2023 | 510 | 51% | — | ||
7Annual Review of ImmunologyAnnual Reviews · United States | 3.36Q1 | 34.23 5.05 up from 2023 | 83 | 100% | — | ||
8Seminars in ImmunopathologySpringer Science+Business Media · Germany | 2.78Q1 | 9.46 0.95 up from 2023 | 159 | 77% | $3,790 | ||
9The Journal of Experimental MedicineRockefeller University Press · United States | 2.65Q1 | 9.45 0.73 down from 2023 | 691 | 100% | — | ||
10Journal of Allergy and Clinical ImmunologyElsevier BV · United States | 2.58Q1 | 8.18 0.51 down from 2023 | 1,124 | 36% | $4,900 | ||
11Journal of AutoimmunityElsevier BV · United Kingdom | 2.48Q1 | 7.72 1.67 down from 2023 | 339 | 66% | $5,420 | ||
12Seminars in ImmunologyElsevier BV · United States | 2.37Q1 | 8.30 0.76 up from 2023 | 204 | 64% | $4,370 | ||
13Mucosal ImmunologyOAElsevier BV · United States | 2.27Q1 | 7.61 0.78 down from 2023 | 282 | 100% | $4,370 | ||
14BioDrugsAdis, Springer Healthcare · Switzerland | 2.05Q1 | 8.43 2.01 up from 2023 | 169 | 74% | $5,190 | ||
15Immunity & AgeingOABioMed Central · United Kingdom | 1.90Q1 | 6.63 0.91 up from 2023 | 181 | 100% | $3,190 | ||
16Frontiers in ImmunologyOAFrontiers Media · Switzerland | 1.89Q1 | 6.53 0.10 up from 2023 | 19,751 | 100% | $3,801 | ||
17Inflammation ResearchSpringer Science+Business Media · Switzerland | 1.54Q1 | 5.62 0.68 up from 2023 | 387 | 27% | $4,790 | ||
18The AAPS JournalSpringer Science+Business Media · United States | 1.52Q1 | 4.02 1.74 down from 2023 | 316 | 39% | $5,090 | ||
19Current Research in ImmunologyElsevier BV · Netherlands | 1.50Q1 | 5.80 1.85 up from 2023 | 70 | 100% | $2,520 | ||
20Psoriasis Targets and TherapyOADove Medical Press · New Zealand | 1.42Q1 | 7.14 0.71 up from 2023 | 42 | 100% | $2,320 | ||
21Genes and ImmunitySpringer Nature · United States | 1.40Q1 | 3.71 2.16 down from 2023 | 120 | 47% | $3,190 | ||
22ImmunologyWiley · United Kingdom | 1.40Q1 | 4.70 0.23 down from 2023 | 396 | 79% | $5,330 | ||
23Immunotherapy AdvancesOAOxford University Press · United Kingdom | 1.34Q2 | 4.36 0.28 down from 2023 | 74 | 100% | $3,053 | ||
24Immune NetworkOASouth Korea | 1.25Q2 | 4.58 0.27 down from 2023 | 142 | 100% | — | ||
25CytokineElsevier BV · United Kingdom | 1.25Q2 | 4.23 0.02 down from 2023 | 767 | 28% | $3,220 | ||
26Clinical ImmunologyElsevier BV · Netherlands | 1.24Q2 | 3.98 0.44 down from 2023 | 641 | 31% | $4,400 | ||
27Clinical & Translational ImmunologyOAWiley · Australia | 1.22Q2 | 4.05 0.95 down from 2023 | 246 | 100% | $3,070 | ||
28International Reviews of ImmunologyTaylor & Francis · United States | 1.21Q2 | 3.29 1.07 down from 2023 | 86 | 19% | — | ||
29Cytokine & Growth Factor ReviewsElsevier BV · United Kingdom | 1.18Q2 | 11.07 0.13 up from 2023 | 152 | 44% | $4,900 | ||
30Trends in ImmunologyElsevier BV · United Kingdom | 1.17Q2 | 7.84 0.56 up from 2023 | 402 | 51% | $7,030 | ||
31BiologicsOAMultidisciplinary Digital Publishing Institute · Switzerland | 1.17Q2 | 2.49 2.98 down from 2023 | 63 | 100% | $1,207 | ||
32Clinical & Experimental ImmunologyOxford University Press · United Kingdom | 1.15Q2 | 3.86 0.15 up from 2023 | 389 | 98% | $3,816 | ||
33Journal of Innate ImmunityOAKarger Publishers · Switzerland | 1.10Q2 | 3.27 1.23 down from 2023 | 135 | 100% | $3,590 | ||
34Expert Opinion on Biological TherapyTaylor & Francis · United Kingdom | 1.09Q2 | 3.86 0.21 up from 2023 | 323 | 38% | — | ||
35European Journal of ImmunologyWiley · Germany | 1.05Q2 | 3.30 0.25 down from 2023 | 692 | 89% | $4,550 | ||
36Immunologic ResearchSpringer Science+Business Media · United States | 1.03Q2 | 3.46 0.31 down from 2023 | 265 | 29% | $2,890 | ||
37Fish & Shellfish ImmunologyElsevier BV · United Kingdom | 1.01Q2 | 4.19 0.28 down from 2023 | 1,817 | 15% | $4,330 | ||
38Journal of Leukocyte BiologyOxford University Press · United States | 0.97Q2 | 2.96 0.60 down from 2023 | 503 | 56% | $3,800 | ||
39International ImmunologyOxford University Press · United Kingdom | 0.95Q2 | 2.78 0.55 down from 2023 | 217 | 60% | $3,530 | ||
40Innate ImmunityOASAGE Publishing · United Kingdom | 0.95Q2 | 2.79 0.18 down from 2023 | 74 | 100% | $2,650 | ||
41Journal of Clinical ImmunologySpringer Science+Business Media · United States | 0.94Q2 | 4.26 0.43 down from 2023 | 669 | 67% | $4,990 | ||
42Human ImmunologyElsevier BV · United States | 0.94Q2 | 1.93 1.34 down from 2023 | 300 | 15% | $3,600 | ||
43Cellular ImmunologyElsevier BV · Netherlands | 0.93Q2 | 3.03 0.46 down from 2023 | 247 | 31% | $3,550 | ||
44BMC ImmunologyOABioMed Central · United Kingdom | 0.92Q2 | 3.04 0.11 down from 2023 | 195 | 100% | $3,090 | ||
45Drugs in R&DOAAdis, Springer Healthcare · New Zealand | 0.92Q3 | 2.39 0.19 down from 2023 | 108 | 100% | $3,490 | ||
46Molecular ImmunologyElsevier BV · Netherlands | 0.91Q3 | 3.01 0.45 down from 2023 | 639 | 36% | $3,340 | ||
47International Journal of InflammationOAHindawi Publishing Corporation · United Kingdom | 0.90Q3 | 2.64 0.10 down from 2023 | 40 | 100% | $1,000 | ||
48Journal of ImmunotoxicologyOAInforma · United States | 0.90Q3 | 3.63 1.48 up from 2023 | 42 | 100% | $2,306 | ||
49Immunology LettersElsevier BV · Netherlands | 0.89Q3 | 3.00 0.31 down from 2023 | 278 | 45% | $3,290 | ||
50The Journal of ImmunologyAmerican Association of Immunologists · United States | 0.88Q3 | 3.14 0.47 down from 2023 | 1,465 | 25% | $3,500 |
Subfields of Immunology and Microbiology, with Immunology highlighted.
Journals
Citations made in 2024. Corpus-wide, 87.1% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
17 additional Immunology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2021–2023, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2024. Publication window: 2021–2023. How these summaries are calculated
- Ranked journals
- 88
- Window papers (baseline)
- 84,353 +9.0% from indicator year 2021
- Median OJR
- 0.922 -1.1% from indicator year 2021
- Rising journals (2025)
- 5
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2021–2023 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 56 | 59 | 63 | 65 | 62 | 64 | 68 | 72 | 71 | 74 | 76 | 79 | 81 | 86 | 83 | 88 | 90 | 96 | 94 | 90 | 92 | 87 | 88 | 88 | 88 | 86 | |
| Window papers (baseline) | 33,673 | 35,811 | 37,963 | 40,362 | 42,065 | 44,849 | 47,600 | 50,960 | 53,923 | 57,726 | 63,072 | 65,596 | 67,601 | 67,579 | 70,684 | 72,624 | 73,354 | 72,790 | 72,098 | 72,447 | 74,045 | 77,362 | 81,615 | 83,779 | 84,353 | 84,391 | |
| Median OJR | 0.72 | 0.78 | 0.834 | 0.82 | 0.830 | 0.88 | 0.89 | 0.959 | 1.002 | 1.15 | 1.100 | 1.09 | 1.096 | 1.04 | 1.08 | 1.06 | 1.05 | 0.95 | 0.921 | 0.970 | 0.931 | 0.932 | 0.967 | 0.956 | 0.922 | 0.87 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.